NSI Equity Snapshot

EMCURE Weekly Equity Report

EMCURE PHARMACEUTICALS L

Interactive chart JSON snapshot
Latest Close 1,736 INR 12 Jun 2026
1W Return -1.2% latest completed week
4W Return 1.8% short-term follow-through
12W Return 17.5% quarterly tape
Trend Breadth 92.3% 48 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
Company Brief

What the company does

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Snapshot

What the weekly tape is saying

EMCURE closed the latest completed week at 1,736 INR. The 4-week return is 1.8% and the 12-week return is 17.5%. Trend Signal is active, Market Dynamics is 1.05. Setup signature: Leadership continuation with a 75/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 12.7%
Volume 1.0x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 96 Persistence of active Trend Signal over the last year and current streak.
Momentum 70 Blend of 4-week and 12-week follow-through.
Dynamics 69 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 41 Participation compared with the 13-week volume baseline.
Risk Control 72 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
1,540 INR
Vs Trend Line
12.7%
Fair Value
1,364 INR
Vs Fair Value
27.2%
52W High
1,830 INR
52W Low
1,226 INR
Drawdown
-5.1%
Range Position
84.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.2%
4W 1.8%
12W 17.5%
26W 20.7%
52W 27.8%

Trend read

Active Streak
48 weeks
52W Active Weeks
48
52W Active Breadth
92.3%
Sector Scope
IN Healthcare
Sector Rank
111 of 161
Sector Percentile
31.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.05
4W MD Change
1.0%
Relative Strength
24.52
4W RS Change
-3.6%
Expectation
Positive
Probability
56.04%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1.1M
13W Average
1.2M
52W Average
1.1M
Vs 13W
1.0x
Vs 52W
1.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.2%
52W Volatility
3.7%
Upside Weeks
28
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
3.4% / -2.8%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NSI
Country
IN
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
INR
Market Cap
321.7B

Opportunity signals

  • Trend Signal is active with a 48-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • No major top-level risk cluster is currently dominant.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 1,736 INR -1.2% 1,540 INR 1,364 INR 1.05 24.52 1.1M On
5 Jun 2026 1,757 INR 3.6% 1,528 INR 1,361 INR 1.01 28.15 580.0K On
29 May 2026 1,696 INR -1.0% 1,515 INR 1,357 INR 1.04 23.67 559.3K On
22 May 2026 1,714 INR 0.5% 1,503 INR 1,353 INR 1.09 24.80 490.6K On
15 May 2026 1,705 INR 3.8% 1,491 INR 1,350 INR 1.04 25.43 984.4K On
8 May 2026 1,643 INR -2.2% 1,479 INR 1,346 INR 0.96 19.40 2.4M On
1 May 2026 1,680 INR 2.6% 1,471 INR 1,343 INR 0.77 24.10 2.2M On
24 Apr 2026 1,637 INR -2.1% 1,460 INR 1,339 INR 0.51 22.61 1.8M On
17 Apr 2026 1,672 INR 4.5% 1,448 INR 1,336 INR 0.54 23.98 818.9K On
10 Apr 2026 1,600 INR 3.4% 1,437 INR 1,332 INR 0.24 21.12 1.0M On
3 Apr 2026 1,548 INR -6.4% 1,429 INR 1,329 INR 0.09 25.17 1.1M On
27 Mar 2026 1,653 INR 11.8% 1,423 INR 1,327 INR -0.17 34.24 1.8M On
20 Mar 2026 1,478 INR 2.8% 1,414 INR 1,323 INR -0.33 19.68 558.9K On
13 Mar 2026 1,438 INR 1.6% 1,415 INR 1,322 INR -0.26 17.08 4.0M On